Pre-Existing Conditions / Prescription History
The role of prescription history in underwriting
Under simplified-issue underwriting, the specific medications an applicant takes can carry weight comparable to the underlying diagnosis. Carriers incorporate a prescription history review as a standard component of the underwriting process. The following addresses the rationale for this practice and its application to several common medication categories.
Rationale for prescription verification
Simplified issue does not incorporate a medical examination, yet carriers require confidence in the accuracy of health disclosures. A prescription history review serves as the primary verification mechanism — a limited, database-driven inquiry rather than a request for complete medical records. Where disclosed information and prescription history are consistent, the review typically expedites approval. Where a discrepancy exists, the outcome may be a decline or a less favorable classification than would otherwise apply, reinforcing the professional importance of complete and accurate disclosure over an optimistic self-characterization.
Certain medications additionally convey information independent of explicit disclosure — a specific combination of prescriptions may function as an indicator of a condition not otherwise mentioned. This is why the medication itself, and not solely the associated diagnosis, factors into the underwriting review.
Medication categories
Anti-Seizure Medication
e.g., Keppra, Dilantin, Lamictal
Typically interpreted as an indicator of an epilepsy or seizure history rather than as an independent concern.
Antidepressants
e.g., Zoloft, Lexapro, Wellbutrin
Among the most frequently encountered prescriptions in underwriting, and rarely an obstacle on its own.
Blood Thinners
e.g., Eliquis, Xarelto, Warfarin
The underlying reason for the prescription carries more underwriting weight than the medication itself.
Opioid Pain Medication
e.g., Oxycodone, Hydrocodone, Tramadol
The most closely scrutinized medication category, as carriers are specifically screening for indications of dependency.